RxSight, Inc.
RXSTMedical Devices
$4.87−3.56%As of Oct 30vs prior close
- Market cap
- $202.6M
- P/E (TTM)
- –
- From 52W high
- −62.80%
- EPS (LTM)
- -$0.95
- Revenue (LTM)
- $128.1M
- Net margin
- -30.65%
- Dividend yield
- 0.00%
Nomior Score
21
Fragile PremiumSpeculativeBottom 8% of the scored universe
Growth47
Quality43
Value32
Momentum19
Resilience30
Growth
+55.74%revenue a year over 5 fiscal years
YE20 $14.7MLTM $128.1M
Connections
Revenue to profitQ2 YE26
The operating loss was 41% of revenue, narrower by 1 pt on a year.
Who owns it
2funds